More on OCS
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $27.74 |
|
|||
| Open | $27.73 | ||||
| 52 Wk High | $8.14 | ||||
| 52 Wk Low | $6.68 | ||||
| Day High | $28.00 | ||||
| Day Low | $26.81 | ||||
| P/E | 898.67 | ||||
| EPS | $0.03 | ||||
| Volume | 266,967 | ||||
- Oculis Holding AG (OCS) PT Raised to $44 at H.C. Wainwright
- Oculis Holding AG (OCS) PT Raised to $50 at Stifel
- Form 6-K Oculis Holding AG For: Mar 04
- Form F-3ASR Oculis Holding AG
- Form 20-F Oculis Holding AG For: Dec 31
- Oculis Holding AG (OCS) PT Raised to $40 at Needham
- Form 6-K Oculis Holding AG For: Mar 03
- Oculis receives FDA breakthrough therapy designation for optic neuritis drug
- Oculis Holding AG (OCS) PT Raised to $40 at Stifel; An 'Under-the-Radar Name'
- JPMorgan Starts Oculis Holding AG (OCS) at Overweight
Entities mentioned with OCS
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Definitive Agreement | View Related Stories »
- Robert W Baird | View Related Stories »
- Stifel | View Related Stories »
- Show More...
